Fund 13F filing

Marshall Wace added $52M of Charles River Laboratories International, Inc. (CRL) stock

SEC Form 13F · Filed Aug 13, 2026

Marshall Wace added $52M of Charles River Laboratories International, Inc. (CRL) stock in the quarter ending Jun 30, 2026, per a 13F filed Aug 13, 2026.

A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.

Bought

CRL

Charles River Laboratories International, Inc.

Value

$52M

Disclosed: Aug 13, 2026
Quarter end: Jun 30, 2026
Source: SEC Form 13F

See the filing

More CRL insider and Congress trades

SellCRL · Shannon M Parisotto$600KAug 20, 2026
SellCRL · Michael Gunnar Knell$1.7MAug 10, 2026
SellCRL · Shannon M Parisotto$1.3MAug 6, 2026
SellCRL · James C Foster$16.9MJul 1, 2026

Share this trade

From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.